Neuromeka Valuation Multiples

Neuromeka is valued at $252M as of November 2026, a 19.9x revenue multiple. In the last fiscal year, Neuromeka revenue was $14M and Neuromeka EBITDA was ($11M).

Neuromeka Overview

About Neuromeka

Neuromeka Co Ltd is a robot company. It is building a robot as a service platform business ecosystem centered on collaborative robots so that even small and medium-sized manufacturing companies without robot experts can introduce and operate robot automation without burden.


Founded

2013

HQ

South Korea

Employees

146

Financials (Last FY)

Revenue: $14M
EBITDA: ($11M)

EV

$282M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Neuromeka Financials

Neuromeka reported last fiscal year revenue of $14M and negative EBITDA of ($11M).

In the same fiscal year, Neuromeka generated $3M in gross profit, ($11M) in EBITDA losses, and had net loss of ($16M).

Revenue (LTM)


Neuromeka P&L

In the most recent fiscal year, Neuromeka reported revenue of $14M and EBITDA of ($11M).

Neuromeka is unprofitable as of last fiscal year, with gross margin of 18%, EBITDA margin of (75%), and net margin of (116%).

See analyst estimates for Neuromeka
Last FY202320242025202620272028
Revenue$14M$10M$19M$14M
Gross Profit$3M$914K$3M$3M
Gross Margin18%9%16%18%
EBITDA($11M)($12M)($8M)($11M)
EBITDA Margin(75%)(114%)(40%)(75%)
EBIT Margin(78%)(108%)(75%)(78%)
Net Profit($16M)($13M)($13M)($16M)
Net Margin(116%)(128%)(66%)(116%)
Net Debt$27M---

Financial data powered by Morningstar, Inc.

Neuromeka Stock Performance

Neuromeka has current market cap of $252M, and enterprise value of $282M.

Market Cap Evolution


Neuromeka's stock price is $12.18.

Neuromeka share price decreased by 1.2% in the last 30 days, and by 2.7% in the last year.

Neuromeka has an EPS (earnings per share) of $-0.79.

See more trading valuation data for Neuromeka
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$282M$252M-1.2%-1.2%-9.7%-2.7%$-0.79

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Neuromeka Valuation Multiples

Neuromeka trades at 19.9x EV/Revenue multiple, and (26.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for Neuromeka

EV / Revenue (LTM)


Neuromeka Financial Valuation Multiples

As of November 3, 2026, Neuromeka has market cap of $252M and EV of $282M.

Neuromeka has a P/E ratio of (15.4x).

Last FY202320242025202620272028
EV/Revenue19.9x27.4x14.9x19.9x
EV/EBITDA(26.4x)(24.0x)(37.3x)(26.4x)
EV/EBIT(25.4x)(25.4x)(19.8x)(25.4x)
EV/Gross Profit109.1xn/m91.0x109.1x
P/E(15.4x)(19.1x)(20.1x)(15.4x)
EV/FCF(26.0x)(8.8x)(10.5x)(26.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Neuromeka Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Neuromeka Margins & Growth Rates

In the most recent fiscal year, Neuromeka reported gross margin of 18%, EBITDA margin of (75%), and net margin of (116%).

See estimated margins and future growth rates for Neuromeka

Neuromeka Margins

Last FY20242025202720282029
Gross Margin18%16%18%
EBITDA Margin(75%)(40%)(75%)
EBIT Margin(78%)(75%)(78%)
Net Margin(116%)(66%)(116%)
FCF Margin(77%)(141%)(77%)

Neuromeka Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth84%(25%)
Gross Profit Growth239%(17%)
EBITDA Growth(36%)41%
EBIT Growth28%(22%)
Net Profit Growth(5%)31%
FCF Growth(17%)(59%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Neuromeka Operational KPIs

Neuromeka's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Neuromeka
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.1M---
S&M Expenses to Revenue10%12%9%10%
G&A Expenses to Revenue7%6%5%7%
R&D Expenses to Revenue29%38%26%29%
Opex to Revenue97%117%92%97%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Neuromeka Competitors

Neuromeka competitors include Hefei Jingsong, Hunan Copote Science, SmartRent, Kodiak AI, Aurotek, Gerard Perrier Industrie, Altınay Savunma, Angel Robotics, Richtech Robotics and Systems Engineering.

Most Neuromeka public comparables operate across Automation & Robotics and Industry 4.0.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Hefei Jingsong$156M$7M1.5x-33.1x-
Hunan Copote Science$79M($63M)3.2x-(4.0x)-
SmartRent$152M($56M)1.1x1.1x(3.1x)(475.8x)
Kodiak AI$4M($577M)96.0x36.8x(0.6x)(2.6x)
Aurotek$77M$8M2.8x-28.7x-
Gerard Perrier Industrie$362M$37M0.8x0.7x7.3x6.8x
Altınay Savunma$63M$9M4.1x-28.2x-
Angel Robotics$3M($6M)52.6x-(28.4x)-

This data is available for Pro users. Sign up to see all Neuromeka competitors and their valuation data.

Start Free Trial

Neuromeka VC Funding History

Before going public, Neuromeka raised $35M in total equity funding, across 4 rounds.


Neuromeka Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Aug-21Series DDSC Investment; The Wells Investment; Lee Soo-up Investment; Atomic Asset Management; Kolon Investment$12M-Neuromeka Co. is a South Korean robotics company that raised Series D funding of KRW 14 billion in 2021. The company expanded its Daejeon branch during this period.
Jan-18Series CWONIK Investment Partners; DAOL Investment & Securities; Intops Investment; DSC Investment; Korea Investment Partners; Korea Development Bank; Lighthouse Investment Group; KT Investment$16M--
May-17Series BWONIK Investment Partners; DAOL Investment & Securities; DSC Investment; Korea Development Bank$5M-Neuromeka, founded in 2013 and based in Seoul, South Korea, specializes in collaborative robotics and automation solutions including cobots and delta robots for laboratory automation, food service, material handling, and manufacturing. The company has raised $54.67M in total funding across multiple rounds with investors including DN Solutions, POSCO, DSC Investment, KOLON Investment, and ISU Venture Capital. Neuromeka designs collaborative robots intended for high-speed, high-precision tasks with safety features for various industrial and cultural applications. The company has filed 11 patents in areas including industrial robotics and industrial robots.
Apr-16Series ADAOL Investment & Securities$2M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Neuromeka

When was Neuromeka founded?Neuromeka was founded in 2013.
Where is Neuromeka headquartered?Neuromeka is headquartered in South Korea.
How many employees does Neuromeka have?As of today, Neuromeka has over 146 employees.
Is Neuromeka publicly listed?Yes, Neuromeka is a public company listed on Korea Exchange.
What is the stock symbol of Neuromeka?Neuromeka trades under 348340 ticker.
When did Neuromeka go public?Neuromeka went public in 2022.
Who are competitors of Neuromeka?Neuromeka main competitors include Hefei Jingsong, Hunan Copote Science, SmartRent, Kodiak AI, Aurotek, Gerard Perrier Industrie, Altınay Savunma, Angel Robotics, Richtech Robotics, Systems Engineering.
What is the current market cap of Neuromeka?Neuromeka's current market cap is $252M.
What is the current revenue of Neuromeka?Neuromeka's last fiscal year revenue is $14M.
What is the current EV/Revenue multiple of Neuromeka?Current revenue multiple of Neuromeka is 19.9x.
Is Neuromeka profitable?No, Neuromeka is not profitable.
How many companies Neuromeka has acquired to date?Neuromeka hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Neuromeka has invested to date?Neuromeka hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Neuromeka

Lists including Neuromeka

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial